Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > What Happens on May 31

<< Previous

Bullboard Posts

Next >>

Post by Forestviewon May 26, 2021 7:34am

362 Views

Post# 33266136

What Happens on May 31

This question has been asked, but never answered. So, on May 31st, do the AH shares get added to the pot overnight, causing a drop in the share price (since Market Cap will be constant). Or, does the the share price stay constant and the market cap increase? Or is there a third scenario? And, if there is a drop in share price, which i think is the more likely scenario, is the drop 11% due to the AH % allocation.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1